Neurological Paraneoplastic Syndromes

Posner JB Neurologic complications of cancer Philadelphia. FA Davis Company; 1995.

Elrington GM , Murray NM , Spiro SG , Newsom-Davis J. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients J Neurol Neurosurg Psychiatry 1991;54:764-767.

Henson RA , Urich H. Cortical cerebellar degeneration. In: Henson RA, Urich H, editors. Cancer and the nervous system Oxford, UK: Blackwell Scientific Publications; 1982. p. 314-345.

Lang B. , Newsom-Davis J. Immunopathology of the Lambert-Eaton myasthemc syndrome Semin Immunopathol 1995;17:3-15.

Lindstrom JD , Shelton A. , Fujii Y. Myasthema gravis Adv Immunol 1988;42:233-284.

Newsom-Davis J. , Murray NM Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthemc syndrome Neurology 1984;34:480-485.

Drachman DB Myasthenia gravis N Eng J Med 1994 ;330:1797-1810.

Sillevis-Smitt PA , Manley GT , Posner JB Immunization with the paraneoplastic antigen HuD does not cause neurologic disease in mice Neurology 1995;45:1873-1878.

Tanaka K. , Tanaka M. , Onodera O. , Igarashi S. , Miyatake T. , Tsuji S. Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration J Neurol Sci 1994 ;127:153-158.

Dalmau J. , Furneaux HM , Gralla RJ , Kris MG , Posner JB Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer: A quantitative western blot analysis Ann Neurol 1990;27:544-552.

Peterson K. , Rosenblum MK , Kotanides H. , Posner JB Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients Neurology 1992;42:1931-1937.

Luque FA , Furneaux HM , Ferziger R., et al. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer Ann Neurol 1991;29:241-251.

Furneaux HM , Reich L. , Posner JB Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes Neurology 1990;40:1085-1091.

Graus F. , Segurado OG , Tolosa E. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration Acta Neurol Scand 1988;78:210-213.

Anderson NE , Rosenblum MK , Graus F. , Wiley RG , Posner JB Autoantibodies in paraneoplastic syndromes associated with small cell lung cancer Neurology 1988;38:1391-1398.

Graus F. , Ribalta T. , Campo E. , Monforte R. , Urbano A. , Rozman C. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis Neurology 1990;40:219-22.

Verschuuren J. , Chuang L. , Rosenblum MK, et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo associated paraneoplastic cerebellar degeneration Acta Neuropathol 1996;91:519-525.

Dalmau J. , Furneaux HM , Rosenblum MK , Graus F. , Posner JB Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy Neurology 1991;41:1757-1764.

Jean WC , Dalmau J. , Ho A. , Posner JB Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu associated paraneoplastic encephalomyelitis Neurology 1994; 44:140-147.

Dalmau J. , Furneaux HM , Cordon-Cardo C. , Posner JB The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues Am J Pathol 1992;141:881-886.

Dalmau J. , Graus F. , Cheung NK, et al. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer Cancer 1995;75:99-109.

Liu S. , Mezrich J. , Berk J. , Federici M. , Dalmau J. , Posner JB Expression of Purkinje-cell antigens in ovarian tumor, and presence of anti-Purkinje cell antibodies in the serum of patients without paraneoplastic cerebellar degeneration [abstract]. Neurology 1995; 45(Suppl 4):A228-A229.

Nobile-Orazio E. , Manfredini E. , Carpo M., et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy Ann Neurol 1994; 36:416-424.

Vallat JM , De Mascarel HA , Bordessoule D., et al. Non-Hodgkin's malignant lymphomas and peripheral neuropathies—13 cases Brain 1995;118:1233-1245.

Gieron MA , Margraf LR , Korthals JK , Gonzalvo AA , Murtagh RF , Hvizdala EV Progressive necrotizing myelopathy associated with leukemia: clinical, pathologic, and MRI correlation J Child Neurol 1987;2:44-49.

Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma J Neurol Neurosurg Psychiatry 1948;11:73-87.

Brain WR , Daniel PM , Greenfield JG Subacute cortical cerebellar degeneration and its relation to carcinoma J Neurol Neurosurg Psychiatry 1951;14:59-75.

Henson RA , Hoffman HL , Unch H. Encephalomyelitis with carcinoma Brain 1965 ;88:449-64.

Elmqvist D. , Lambert EH Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma Mayo Clin Proc 1968; 43:689-713.

Mancall EL , Rosales RK Necrotizing myelopathy associated with visceral carcinoma Brain 1964;87:639-659.

Dalmau J. , Graus F. , Rosenblum MK , Posner JB Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients Medicine 1992;71:59-72.

Mason WP , Graus F. , Lang B., et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome Brain 1997;120:1279-1300.

Graus F. , Dalmau J. , Valldeoriola F., et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease J Neuroimmunol 1997;74:55-61.

Graus F. , Dalmau J. , Rene R., et al. Anti-Hu antibodies in patients with small cell lung cancer: association with complete response to therapy and improved survival J Clin Oncol 1997;15:2866-2872.

Hetzel DJ , Stanhope R. , O'Neill BP , Lennon VA Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume Mayo Clin Proc 1990;65:1558-1563.

Dalmau J. , Graus F. Paraneoplastic syndromes of the nervous system In: Black PMcL, Loeffler JS, editors. Cancer of the nervous system. Oxford, UK: Blackwell Scientific Publications; 1997. p. 674-700.

Dirr LY , Elster AD , Donofrio PD , Smith M. Evolution of brain MRI abnormalities in limbic encephalitis Neurology 1990;40: 1304-1306.

Glantz MJ , Biran H. , Myers ME , Gockerman JP , Friedberg MH The radiographic diagnosis and treatment of paraneoplastic central nervous system disease Cancer 1994;73:168-175.

Alamowitch S. , Graus F. , Uchuya M. , Reñé R. , Bescansa E. , Delattre J-Y. Limbic encephalitis and small cell lung cancer: clinical and immunological features Brain 1997;120:923-928.

Ito H. , Sayama S. , Ine S., et al. Antmeuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection Neurology 1994;44:1506-1507.

Saiz A. , Arpa J. , Sagasta A., et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocnne autoimmumty Neurology 1997;49.1026-1030.

Brashear HR , Greenlee JE , Jaeckle KA , Rose JW Anticerebellar antibodies in neurologically normal patients with ovarian neoplasm Neurology 1989;39:1605-1609.

O'Neill JH , Murray Nmf , Newsom-Davis J. The Lambert-Eaton myasthemc syndrome A review of 50 cases Brain 1988;111:577-596.

Motomura M. , Lang B. , Johnston I. , Palace J. , Vincent A. , Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthemc syndrome J Neurol Sci 1997;147:35-42

Chalk CH , Murray NM , Newsom-Davis J. , O'Neill JH , Spiro SG Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma Neurology 1990;40: 1552-1556

Barn PG , Motomura M. , Newsom-Davis J., et al. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome Neurology 1996;47:678-683.

Chalk CH , Windebank AJ , Kimmel DW, et al. The distinctive clinical features of paraneoplastic sensory neuronopathy Can J Neurol Sci 1992;19:346-351.

Cohn SL , Salwen H. , Herst CV, et al. Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus Cancer 1988;62:723-726.

Connolly AM , Pestronk A. , Mehta S. , Pranzatelli MR , Noetzel MJ Serum autoantibodies in childhood opsoclonus-myoclonus syndrome : an analysis of antigenic targets in neural tissues J Pediatncs 1997;130:878-884.

Russo C. , Cohn SL , Petruzzi MJ , Alarcon PA Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the pediatric oncology group Med Pediatr Oncol 1997;28:284-288.

Anderson NE , Budde-Steffen C. , Rosenblum MK, et al. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer : A distinct paraneoplastic syndrome Medicine 1988;67:100-109.

Casado JL , Gil-Peralta A. , Graus F. , Arenas C. , Lopez JM , Alberca R. Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity Neurology 1994;44:1521-1522.

Dropcho EJ , Kline LB , Riser J. Antineuronal (anti-Ri) autoantibodies in a patient with steroid-responsive opsoclonus myoclonus Neurology 1993;43:207-211.

Shilhto P. , Molenaar PC , Vincent A., et al. Acquired neuromyotoma : evidence for autoantibodies directed against K+ channels of peripheral nerves Ann Neurol 1995;38:714-722.